These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38660514)

  • 1. Association of glycogen synthase kinase-3β with cognitive impairment in type 2 diabetes patients: a six-year follow-up study.
    Wei W; Xu P; Li L; Mao H; Li N; Wang XQ; Wang L; Xu ZP; Zhao S
    Front Endocrinol (Lausanne); 2024; 15():1386773. PubMed ID: 38660514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3β activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross-sectional study.
    Gao Y; Yu H; Liu Y; Xu Z; He B; Liu H; Wang Y; Zhang Y; Liang Y; Yang Y; Zheng J; Wang JZ
    J Diabetes; 2024 Jan; 16(1):e13470. PubMed ID: 37700547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
    Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
    Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients.
    Yu H; Liu Y; He T; Zhang Y; He J; Li M; Jiang B; Gao Y; Chen C; Ke D; Liu J; He B; Yang X; Wang JZ
    Aging Cell; 2021 Oct; 20(10):e13469. PubMed ID: 34528736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients.
    Liu Y; Zhang S; He B; Chen L; Ke D; Zhao S; Zhang Y; Wei W; Xu Z; Xu Z; Yin Y; Mo W; Li Y; Gao Y; Li S; Wang W; Yu H; Wu D; Pi G; Jiang T; Deng M; Xiong R; Lei H; Tian N; He T; Sun F; Zhou Q; Wang X; Ye J; Li M; Hu N; Song G; Peng W; Zheng C; Zhang H; Wang JZ
    Front Cell Dev Biol; 2021; 9():752753. PubMed ID: 34746146
    [No Abstract]   [Full Text] [Related]  

  • 7. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
    Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
    JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
    Ren D; Lopez OL; Lingler JH; Conley Y
    J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus.
    Salama II; Sami SM; Abdellatif GA; Mohsen A; Rasmy H; Kamel SA; Ibrahim MH; Mostafa M; Fouad WA; Raslan HM
    PLoS One; 2020; 15(7):e0236453. PubMed ID: 32726329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.
    Liew TM
    Aust N Z J Psychiatry; 2022 Dec; 56(12):1664-1675. PubMed ID: 35229693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.
    Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G
    J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ApoE4 increases glycogen synthase kinase 3β expression and Tau phosphorylation in U87 cells].
    He YJ; Wei PR; Wu QY; Zhang XY; Zhang XM; Liu XJ; Wang F
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(7):904-8. PubMed ID: 27435766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.
    Teixeira AL; Diniz BS; Campos AC; Miranda AS; Rocha NP; Talib LL; Gattaz WF; Forlenza OV
    Neuromolecular Med; 2013 Mar; 15(1):115-21. PubMed ID: 23055000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periphery Biomarkers Predicting Conversion of Type 2 Diabetes to Pre-Alzheimer-Like Cognitive Decline: A Multicenter Follow-Up Study.
    Liu Y; He B; Du K; Zheng J; Ke D; Mo W; Li Y; Jiang T; Xiong R; Sun F; Zhao S; Wei W; Xu Z; Zhang S; Li S; Wang X; Zhou Q; Ye J; Liang Y; Lin H; Liu Y; Chen L; Zhang H; Zhang Y; Gao Y; Wang JZ
    J Alzheimers Dis; 2024; 100(s1):S115-S129. PubMed ID: 39058442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment.
    Tian S; Han J; Huang R; Sun J; Cai R; Shen Y; Wang S
    J Alzheimers Dis; 2017; 58(4):1163-1173. PubMed ID: 28550262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
    Sakurai R; Montero-Odasso M
    J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
    Tropea TF; Xie SX; Rick J; Chahine LM; Dahodwala N; Doshi J; Davatzikos C; Shaw LM; Van Deerlin V; Trojanowski JQ; Weintraub D; Chen-Plotkin AS
    Mov Disord; 2018 Feb; 33(2):289-297. PubMed ID: 29168904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.
    Boyle PA; Buchman AS; Wilson RS; Kelly JF; Bennett DA
    Neuroepidemiology; 2010; 34(1):43-9. PubMed ID: 19907191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.